📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy. (2023)

First Author: Young KG

Attributed to: Developing a decision support tool to enable precision treatment of type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12933-023-02032-x

PubMed Identifier: 37919773

Publication URI: http://europepmc.org/abstract/MED/37919773

Type: Journal Article/Review

Volume: 22

Parent Publication: Cardiovascular diabetology

Issue: 1

ISSN: 1475-2840